Vermont Gov. Phil Scott (R) this week signed a bill into law to create a psychedelic-assisted therapy working group that will make recommendations on whether and how the state should regulate legal access to substances such as psilocybin and MDMA. The governor vetoed separate legislation, however, that would have established a safe drug consumption facility in Burlington as part of a harm-reduction pilot program.
On Wednesday, Scott signed S.114, the psychedelics working group bill. The new law does not itself change the legal status psychedelics. Rather, it creates an eight-person task force to “review the latest research and evidence of the public health benefits and risks of clinical psychedelic assisted treatments” and “examine the laws and programs of other states that have authorized the use of psychedelics by health care providers in a therapeutic setting.”
Both MDMA and psilocybin have been granted breakthrough therapy status by the Food and Drug Administration (FDA), and recent clinical trials have MDMA on pace for possible FDA approval later this year.
A separate bill, H.72, would have legalized and funded a facility in Burlington where people could use drugs in a medically supervised environment and also have substances checked for adulterants. The pilot project would
Read full article on Marijuana Moment
